Scorpius Holdings Inc (SCPX)
0.735
+0.02
(+2.67%)
USD |
NYAM |
Nov 04, 16:00
0.75
+0.02
(+2.04%)
After-Hours: 20:00
Scorpius Holdings Debt to Equity Ratio: 0.1046 for June 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.1046 |
| March 31, 2024 | 0.0728 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.41 |
| June 30, 2016 | 1.746 |
| March 31, 2016 | 1.042 |
| December 31, 2015 | 1.665 |
| September 30, 2015 | 0.487 |
| June 30, 2015 | 0.3342 |
| March 31, 2015 | 0.141 |
| December 31, 2014 | 0.2305 |
| September 30, 2014 | 0.0791 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.5733 |
| March 31, 2013 | 0.5064 |
| December 31, 2012 | -0.6409 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
0.1046
Maximum
Jun 2024
0.0093
Average
--
Median
Dec 2019
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | -1.128 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | 0.0461 |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 46.69M |
| Total Liabilities (Quarterly) | 24.83M |
| Shareholders Equity (Quarterly) | 25.61M |
| Current Ratio | 0.3193 |
| Net Debt Paydown Yield | -17.93% |